Treatment of relapsing acute promyelocytic leukemia (APL) by all-trans retinoic acid (ATRA) therapy followed by timed sequential chemotherapy and stem cell transplantation (SCT).

被引：0
|
作者：
Thomas, X
Dombret, H
Sadoun, A
Guerci, A
Cahn, JY
Cordonnier, C
Reman, O
Travade, P
Gratecos, N
Gardin, C
Cousin, T
Vekhoff, A
Stamatoullas, A
Fegueux, N
de Revel, T
Maloisel, F
Chomienne, C
Degos, L
Fenaux, P
机构：
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1323
引用
收藏
页码：323A / 323A
页数：1
相关论文
共 50 条
  • [21] Myelodysplastic syndrome (MDS) transforming to acute promyelocytic leukemia (APL) with sustained response to all-trans retinoic acid (ATRA).
    Lima, CMR
    Stuart, RK
    BLOOD, 1996, 88 (10) : 3433 - 3433
  • [22] All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL)
    Orfali, Nina
    O'Donovan, Tracey R.
    Cahill, Mary R.
    Benjamin, Dalyia
    Nanus, David M.
    McKenna, Sharon L.
    Gudas, Lorraine J.
    Mongan, Nigel P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (03) : 236 - 250
  • [23] Dronabinol induces neutrophilic differentiation comparable to all-trans retinoic acid (ATRA) in native acute promyelocytic leukemia (APL)
    Haeusser, L.
    Schittenhelm, M.
    Vogel, W.
    Kanz, L.
    Kampa-Schittenhelm, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 54 - +
  • [24] FATAL THROMBOSIS COMPLICATING ALL-TRANS-RETINOIC ACID (ATRA) THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    BROUNS, MC
    DELOUGHERY, TG
    NICHOLS, MJ
    BLOOD, 1994, 84 (10) : A616 - A616
  • [25] ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EXPERIENCE OF ARGENTINA WITH ALL-TRANS-RETINOIC ACID (ATRA) IN INDUCTION THERAPY
    NUCIFORA, E
    GOLDSZTEIN, R
    KUSMINSKY, G
    FANTL, D
    LABANCA, V
    PONZINIBIO, C
    IASTREBNER, M
    MONSALVE, R
    AGGIO, M
    FUCHS, CR
    BINAGHI, A
    SASLAVSKY, J
    FLORES, A
    STARIHA, M
    BLOOD, 1993, 82 (10) : A544 - A544
  • [26] PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA)
    WANG, ZY
    CHEN, Z
    HUANG, W
    LI, XS
    LU, JX
    HUANG, LA
    ZHANG, FQ
    GU, LJ
    OUYANG, RR
    CHEN, SJ
    SUN, GL
    BLOOD CELLS, 1993, 19 (03): : 633 - 641
  • [27] MORBIDITY FOLLOWING TREATMENT WITH ALL-TRANS-RETINOIC ACID (ATRA) IN CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    MAHMOUD, H
    HURWITZ, C
    ROBERTS, M
    SANTANA, V
    RIBEIRO, R
    KRANCE, R
    BLOOD, 1993, 82 (10) : A249 - A249
  • [28] Therapy of acute promyelocytic leukemia:: All-trans retinoic acid and beyond
    Tallman, MS
    LEUKEMIA, 1998, 12 : S37 - S40
  • [29] Re-administration of all-trans Retinoic Acid (ATRA) after ATRA-induced Acute Pancreatitis in Pediatric Acute Promyelocytic Leukemia (APL)
    Daifu, Tomoo
    Kato, Itaru
    Ogata, Hideto
    Kamitori, Tatsuya
    Mikami, Takashi
    Umeda, Katsutsugu
    Hiramatsu, Hidefumi
    Takahashi, Hiroyuki
    Adachi, Souichi
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S70 - S70
  • [30] ALL-TRANS-RETINOIC ACID (ATRA) AS A TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    GOMEZFUENTES, GH
    LABARDINIMENDEZ, J
    HURTADOMONROY, R
    VELAZQUEZGONZALEZ, A
    MIJANGOSHUESCA, FJ
    LOARCAPINA, LM
    BLOOD, 1994, 84 (10) : A619 - A619
12345